Istore: a project on innovative statistical methodologies to improve rare diseases clinical trials in limited populations
Abstract Background The conduct of rare disease clinical trials is still hampered by methodological problems. The number of patients suffering from a rare condition is variable, but may be very small and unfortunately statistical problems for small and finite populations have received less considera...
Main Authors: | Stefanie Schoenen, Johan Verbeeck, Lukas Koletzko, Isabella Brambilla, Mathieu Kuchenbuch, Maya Dirani, Georg Zimmermann, Holger Dette, Ralf-Dieter Hilgers, Geert Molenberghs, Rima Nabbout |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-03-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13023-024-03103-2 |
Similar Items
-
Multi-stakeholder sessions on major innovation topics in rare disease clinical trials
by: Daniel Bodden, et al.
Published: (2024-12-01) -
The impact of allocation bias on test decisions in clinical trials with multiple endpoints using multiple testing strategies
by: Stefanie Schoenen, et al.
Published: (2024-09-01) -
Composite endpoints, including patient reported outcomes, in rare diseases
by: Johan Verbeeck, et al.
Published: (2023-09-01) -
Endpoints: types, selection, interpretation of the results obtained on the example of cardiology studies
by: A. R. Navasardyan, et al.
Published: (2022-06-01) -
External validation of the IAIHG autoimmune hepatitis response criteria in a multicentric real-world cohort
by: Lorenz Grossar, et al.
Published: (2024-09-01)